[The effect of the monoamine oxidase inhibitor iproniazio on fat metabolism and catecholamine dynamics in tissues].
D000311:Adrenal Glands / Q000032:analysis; D000818:Animals; D002151:Calorimetry; D002395:Catecholamines / Q000032:analysis / Q000502:physiology*; D007279:Injections, Subcutaneous; D007490:Iproniazid / Q000494:pharmacology*; D008049:Lipase / Q000097:blood; D008053:Lipid Mobilization / Q000187:drug effects*; D008099:Liver / Q000032:analysis; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009132:Muscles / Q000032:analysis; D009206:Myocardium / Q000032:analysis; D051381:Rats; D013050:Spectrometry, Fluorescence
D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D007490:Iproniazid; D008049:Lipase
Vliianie ingibitora monoaminoksidazy iproniazida na zhirovoi obmen i dinamkiu katekholaminov v tkaniakh.